Related references
Note: Only part of the references are listed.Axon-Myelin Unit Blistering as Early Event in MS Normal Appearing White Matter
Antonio Luchicchi et al.
ANNALS OF NEUROLOGY (2021)
Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes
Michael Hecker et al.
MOLECULAR NEUROBIOLOGY (2021)
Nile Red fluorescence spectroscopy reports early physicochemical changes in myelin with high sensitivity
Wulin Teo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis
Ellen F. Mosleth et al.
SCIENTIFIC REPORTS (2021)
Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis
Bert A. 't Hart et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Epstein-Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
Amit Bar-Or et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Multiple Sclerosis-Like Symptoms in Mice Are Driven by Latent γHerpesvirus-68 Infected B Cells
Ana Citlali Marquez et al.
FRONTIERS IN IMMUNOLOGY (2020)
The science and medicine of human immunology
Bali Pulendran et al.
SCIENCE (2020)
Glatiramer acetate: A complex drug beyond biologics
Paolo Rocco et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Trends in clinical success rates and therapeutic focus
Helen Dowden et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
J. William L. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The role of infections in multiple sclerosis
Mariano Marrodan et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis
Michael P. Pender et al.
JCI INSIGHT (2018)
Reverse Translation for Assessment of Confidence in Animal Models of Multiple Sclerosis for Drug Discovery
Bert A. 't Hart et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
Egle Cekanaviciute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
Kerstin Berer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Humanized mouse models for Epstein Barr virus infection
Christian Muenz
CURRENT OPINION IN VIROLOGY (2017)
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis
Jordon Dunham et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2016)
The Central Nervous System and the Gut Microbiome
Gil Sharon et al.
CELL (2016)
Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid
Christian Schlaeger et al.
NATURE (2016)
Normalizing the environment recapitulates adult human immune traits in laboratory mice
Lalit K. Beura et al.
NATURE (2016)
Guillain-Barre syndrome: a century of progress
John A. Goodfellow et al.
NATURE REVIEWS NEUROLOGY (2016)
EBV Infection and Multiple Sclerosis: Lessons from a Marmoset Model
Bert A. 'tHart et al.
TRENDS IN MOLECULAR MEDICINE (2016)
Secondary Procression in Multiple Sclerosis: Neuronal Exhaustion or Distinct Pathology?
Catherine Larochelle et al.
TRENDS IN NEUROSCIENCES (2016)
Steroid Resistant CD8+CD28null NKT-Like Pro-inflammatory Cytotoxic Cells in Chronic Obstructive Pulmonary Disease
Greg Hodge et al.
FRONTIERS IN IMMUNOLOGY (2016)
Primate autoimmune disease models; lost for translation?
Bert A. 't Hart
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2016)
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
H. -Christian von Buedingen et al.
EUROPEAN NEUROLOGY (2015)
Cytomegalovirus: a culprit or protector in multiple sclerosis?
Marjan Vanheusden et al.
TRENDS IN MOLECULAR MEDICINE (2015)
The Charcot Lecture vertical bar Beating MS: A story of B cells, with twists and turns
Stephen L. Hauser
MULTIPLE SCLEROSIS JOURNAL (2015)
Macrophage subsets and microglia in multiple sclerosis
Jeroen F. J. Bogie et al.
ACTA NEUROPATHOLOGICA (2014)
Improvement of preclinical animal models for autoimmune-mediated disorders via reverse translation of failed therapies
Bert A. 't Hart et al.
DRUG DISCOVERY TODAY (2014)
Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Michael P. Pender et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2014)
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
Shailender Singh et al.
ACTA NEUROPATHOLOGICA (2013)
Chronic autoimmune-mediated inflammation: a senescent immune response to injury
Bert A. 't Hart et al.
DRUG DISCOVERY TODAY (2013)
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model
S. Anwar Jagessar et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Unravelling the T-cell-mediated autoimmune attack on CNS myelin in a new primate EAE model induced with MOG34-56 peptide in incomplete adjuvant
S. Anwar Jagessar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys
S. Anwar Jagessar et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2012)
Animal models of multiple sclerosis: the good, the bad and the bottom line
Richard M. Ransohoff
NATURE NEUROSCIENCE (2012)
Will the real multiple sclerosis please stand up?
Peter K. Stys et al.
NATURE REVIEWS NEUROSCIENCE (2012)
B-Cell Depletion Attenuates White and Gray Matter Pathology in Marmoset Experimental Autoimmune Encephalomyelitis
Yolanda S. Kap et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
Kerstin Berer et al.
NATURE (2011)
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Yun Kyung Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Breaking Free of Sample Size Dogma to Perform Innovative Translational Research
Peter Bacchetti et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
EAE: imperfect but useful models of multiple sclerosis
Bert A. 't Hart et al.
TRENDS IN MOLECULAR MEDICINE (2011)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
Multiple sclerosis - a response-to-damage model
Bert A. 't Hart et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis, in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells
Yolanda S. Kap et al.
JOURNAL OF IMMUNOLOGY (2008)
Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
Benjamin M. Segal et al.
LANCET NEUROLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
CD4+CD28null T cells in autoimmune disease:: Pathogenic features and decreased susceptibility to immunoregulation
Marielle Thewissen et al.
JOURNAL OF IMMUNOLOGY (2007)
The origin and application of experimental autoimmune encephalomyelitis
Alan G. Baxter
NATURE REVIEWS IMMUNOLOGY (2007)
EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis
RM Ransohoff
TRENDS IN IMMUNOLOGY (2006)
Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
S Sriram et al.
ANNALS OF NEUROLOGY (2005)
Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects
AW Sylwester et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Brief report - Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
BK Kleinschmidt-DeMasters et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Blocking adhesion molecules as therapy for multiple sclerosis: Natalizumab
L Steinman
NATURE REVIEWS DRUG DISCOVERY (2005)
Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosis
B Bielekova et al.
JOURNAL OF IMMUNOLOGY (2004)
Of mice and not men: Differences between mouse and human immunology
J Mestas et al.
JOURNAL OF IMMUNOLOGY (2004)
The CD4-Thl model for multiple sclerosis: a crucial re-appraisal
H Lassmann et al.
TRENDS IN IMMUNOLOGY (2004)
Erratum: The CD4-Th1 model for multiple sclerosis: a crucial re-appraisal (vol 25, pg 132, 2004)
H Lassmann et al.
TRENDS IN IMMUNOLOGY (2004)
NK-CTLs, a novel HLA-E-restricted T-cell subset
L Moretta et al.
TRENDS IN IMMUNOLOGY (2003)
Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p4O monoclonal antibody
HPM Brok et al.
JOURNAL OF IMMUNOLOGY (2002)
IFN-β-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism:: Relevance to IFN-β-1b therapeutic effects in multiple sclerosis
X Wang et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
